Novartis Pharmaceutical Manufacturing GmbH (full production cycle; batch control)
UkraineAll drugs from this manufacturer
-
The drug is prescribed for the treatment of rheumatoid arthritis, juvenile rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, plaque psoriasis, hidradenitis suppurativa, Crohn's disease, ulcerative colitis, and uveitis.
Dosage form: solution for injection
Active substance Dosage adalimumab 100 mg/ml ATC: L04AB04
-
The drug is prescribed for the treatment of rheumatoid arthritis, juvenile rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, plaque psoriasis, pyoderma gangrenosum (hidradenitis suppurativa), Crohn's disease, ulcerative colitis, and uveitis.
Dosage form: solution for injection
Active substance Dosage adalimumab 50 mg/ml ATC: L04AB04
-
The drug is used for the treatment of osteoporosis in postmenopausal women and in men at increased risk of fractures. It is also prescribed for the treatment of bone loss in men receiving hormone suppression therapy for prostate cancer, and for adults experiencing bone loss due to long-term glucocorticoid use.
Dosage form: solution for injection
Active substance Dosage denosumab 60 mg/ml ATC: M05BX04